Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Infectious Disease: COVID-19
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 186 results found since Jan 2013.
In Response (letter 2)
We thank Drs. Siang Kow and Shahzad Hasan for their contemporary comments on our report on Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature.1 We acknowledge our study period of CVST patients with COVID-19 covered March 1, 2020 to November 8, 2020, which preceded the COVID-19 vaccine roll-out in December 2020.
Source: Journal of Stroke and Cerebrovascular Diseases - May 25, 2021 Category: Neurology Authors: Mohamad Abdalkader, James E. Siegler, Thanh N. Nguyen Source Type: research
In Response (letter 1)
We thank Drs Vuorio, Kaste, and Kovanen for their comment on our report on Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature 1.
Source: Journal of Stroke and Cerebrovascular Diseases - May 25, 2021 Category: Neurology Authors: Mohamad Abdalkader, James E. Siegler, Thanh N. Nguyen Source Type: research
Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
To assess the association of COVID-19 vaccines and non-COVID-19 vaccines with cerebral venous sinus thrombosis (CVST).
Source: Journal of Stroke and Cerebrovascular Diseases - June 16, 2021 Category: Neurology Authors: Colin Pawlowski, John Rinc ón-Hekking, Samir Awasthi, Viral Pandey, Patrick Lenehan, AJ Venkatakrishnan, Sairam Bade, John C. O'Horo, Abinash Virk, Melanie D. Swift, Amy W. Williams, Gregory J. Gores, Andrew D. Badley, John Halamka, Venky Soundararajan Source Type: research
National Trends in Telestroke Utilization in a US Commercial Platform prior to the COVID-19 Pandemic
Most data on telestroke utilization come from single academic hub-and-spoke telestroke networks. Our objective was to describe characteristics of telestroke consultations among a national sample of telestroke sites on one of the most commonly used common vendor platforms, prior to the COVID-19 public health emergency.
Source: Journal of Stroke and Cerebrovascular Diseases - August 6, 2021 Category: Neurology Authors: Kori S. Zachrison, Richa Sharma, Yulun Wang, Ateev Mehrotra, Lee H. Schwamm Source Type: research
Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine
We report a fatal case of vaccine-induced immune thrombotic thrombocytopenia (VITT) after receiving the first dose of the ChAdOx1 nCoV-19 vaccine.
Source: Journal of Stroke and Cerebrovascular Diseases - June 22, 2021 Category: Neurology Authors: Yasser Aladdin, Hussein Algahtani, Bader Shirah Tags: Case Report Source Type: research
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation.
Novel coronavirus disease 2019 (COVID-19) has caused confirmed infections in more than 30 million Americans by April 2021, and 130 million worldwide, with a case fatality rate of up to 2-10% (https://ourworldindata.org/coronavirus/). It can cause ischemic and hemorrhagic strokes secondary to coagulopathy and endothelial injury.1 These same factors play a role in Cerebral Cavernous Malformation (CCM), a uncommon hemorrhagic neurovascular disease characterized by grossly dilated vascular “caverns” lined by a single layer of dysfunctional endothelium.
Source: Journal of Stroke and Cerebrovascular Diseases - September 7, 2021 Category: Neurology Authors: Abdallah Shkoukani, Abhinav Srinath, Agnieszka Stadnik, Romuald Girard, Robert Shenkar, Adrienne Sheline, Kristen Dahlem, Cornelia Lee, Kelly Flemming, Issam A. Awad Tags: RESEARCH LETTER Source Type: research
Reversible Cerebral Vasoconstriction Syndrome in Patients with Coronavirus Disease: A Multicenter Case Series
: RCVS (Reversible Cerebral Vasoconstrictive Syndrome) is a condition associated with vasoactive agents that alter endothelial function. There is growing evidence that endothelial inflammation contributes to cerebrovascular disease in patients with coronavirus disease 2019 (COVID-19). In our study, we describe the clinical features, risk factors, and outcomes of RCVS in a multicenter case series of patients with COVID-19.
Source: Journal of Stroke and Cerebrovascular Diseases - September 16, 2021 Category: Neurology Authors: Kristine Arandela, Shilpa Samudrala, Mohamad Abdalkader, Pria Anand, Ali Daneshmand, Hormuzdiyar Dasenbrock, Thanh Nguyen, Charlene Ong, Courtney Takahashi, Julie Shulman, Marc Alain Babi, Sanjeev Sivakumar, Neel Shah, Sandip Jain, Samyuktha Anand, Christ Tags: Original article Source Type: research
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation
Novel coronavirus disease 2019 (COVID-19) has caused confirmed infections in more than 30 million Americans by April 2021, and 130 million worldwide, with a case fatality rate of up to 2-10% (https://ourworldindata.org/coronavirus/). It can cause ischemic and hemorrhagic strokes secondary to coagulopathy and endothelial injury.1 These same factors play a role in Cerebral Cavernous Malformation (CCM), an uncommon hemorrhagic neurovascular disease characterized by grossly dilated vascular “caverns” lined by a single layer of dysfunctional endothelium.
Source: Journal of Stroke and Cerebrovascular Diseases - September 7, 2021 Category: Neurology Authors: Abdallah Shkoukani, Abhinav Srinath, Agnieszka Stadnik, Romuald Girard, Robert Shenkar, Adrienne Sheline, Kristen Dahlem, Cornelia Lee, Kelly Flemming, Issam A. Awad Tags: Short Communication Source Type: research
Hypercoagulability of COVID-19 and Neurological Complications: A Review
The SARS-CoV-2 virus, which causes Coronavirus disease 2019 (COVID-19), has resulted in millions of worldwide deaths. When the SARS-CoV-2 virus emerged from Wuhan, China in December 2019, reports of patients with COVID-19 revealed that hospitalized patients had acute changes in mental status, cognition, and encephalopathy. Neurologic complications can be a consequence from overall severity of the systemic infection, direct viral invasion of the SARS-CoV-2 virus in the central nervous system, and possible immune mediated mechanisms.
Source: Journal of Stroke and Cerebrovascular Diseases - October 26, 2021 Category: Neurology Authors: Patrick Moore, Fatema Esmail, Shuai Qin, Sucha Nand, Stephanie Berg Tags: Review Article Source Type: research
Cerebrovascular involvement in mucormycosis in COVID-19 pandemic
We describe clinico-radiological manifestations of cerebrovascular complications observed in CAM.
Source: Journal of Stroke and Cerebrovascular Diseases - November 21, 2021 Category: Neurology Authors: Rahul Kulkarni, Shripad S Pujari, Dulari Gupta, Pawn Ojha, Megha Dhamne, Vyankatesh Bolegave, Pramod Dhonde, Anand Soni, Sikandar Adwani, Anand Diwan, Dhananjay Duberkar, Dhruv Batra, Rushikesh Deshpande, Kaustubh Aurangabadkar, Nilesh Palasdeokar Source Type: research
Fulminant reversible cerebral vasoconstriction syndrome in breakthrough COVID 19 infection
We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fully vaccinated 2 months back, presented with headache, drowsiness, partial seizures, visual impairment and quadriplegia. Her nasopharyngeal swab was tested positive for SARS COV2 on real time PCR assay.
Source: Journal of Stroke and Cerebrovascular Diseases - November 25, 2021 Category: Neurology Authors: Somdattaa Ray, Vikram V Kamath, Arjun Raju P, Rajesh K.N, Shalini N Source Type: research
Management and outcomes of COVID – 19 associated Cerebral Venous Sinus Thrombosis
Systemic hyper-coagulabilty leading to micro and macro thrombosis is a known complication of Coronavirus disease – 2019(COVID -19). The postulated mechanism appears to be the viral activation of endothelium, triggering the coagulation pathways. Thrombosis of the cerebral veins and sinuses (CVT), a potentially serious condition, has been increasingly reported with COVID – 19 infection. In this clinical stud y we attempt to describe the clinical profile, investigations and outcomes of patients with COVID- 19 associated CVT.
Source: Journal of Stroke and Cerebrovascular Diseases - January 9, 2022 Category: Neurology Authors: Miraclin T Angel, Sanjith Aaron, Ajith Sivadasan, Kenneth Benjamin, Vanjare Harshad, Shalini Nair, KPP Abhilash, Prabhakar AT, Vivek Mathew Source Type: research
The hospitalization rate of cerebral venous sinus thrombosis before and during COVID-19 pandemic era: A single-center retrospective cohort study
In this study, we aimed to compare the hospitalization rate of CVST before and during the COVID-19 pandemic (before vaccination program).
Source: Journal of Stroke and Cerebrovascular Diseases - March 24, 2022 Category: Neurology Authors: Maryam Vasaghi Gharamaleki, Maryam Habibagahi, Etrat Hooshmandi, Reza Tabrizi, Shahram Arsang-Jang, Zohreh Barzegar, Nima Fadakar, Vahid Reza Ostovan, Abbas Rahimi-Jaberi, Nahid Ashjazadeh, Peyman Petramfar, Maryam Poursadeghfard, Sadegh Izadi, Masoumeh N Source Type: research
Isolated and Combined Unilateral Central Retinal Artery and Vein Occlusions After Vaccination. A Review of the Literature
Retinal artery occlusion (RAO), especially central RAO, is a sight-threatening and potentially blinding ophthalmic emergency. Recent publications reported its association with coronavirus disease 2019 (COVID-19) mRNA vaccines. Although rare, vaccines have been linked to ophthalmic complications, and it is of interest to examine the current literature on vaccine-related RAO.
Source: Journal of Stroke and Cerebrovascular Diseases - May 12, 2022 Category: Neurology Authors: Clarice, Kai-ying Su, Sunny, Chi Lik Au Tags: Short Communication Source Type: research
Vaccine-related retinal artery occlusion in adults: a review of the current literature
First of all, I am pleased to have an opportunity to discuss our recently published review on vaccine-related retinal artery occlusion (RAO) in adults.1 Publication and reporting bias are well known in medical research,2 and time lag bias is unavoidable in major public healthcare event as if COVID-19 vaccination.3 Our review clearly listed out the literature search methods on search engine and database used (MEDLINE and PubMed), keywords and MeSH terms applied (vaccine retinal artery occlusion), as well as the date of the search (10th January 2022).
Source: Journal of Stroke and Cerebrovascular Diseases - August 8, 2022 Category: Neurology Authors: Maggie Yeung, Clarice Kai-ying Su, Sunny Chi Lik Au Source Type: research
